Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
04/2006
04/06/2006US20060074240 Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline
04/06/2006US20060074119 Thiophene compounds
04/06/2006US20060074102 Kinase inhibitors as therapeutic agents
04/06/2006US20060074083 Cyclic and acyclic propenones for treating CNS disorders
04/06/2006US20060074030 For cancer therapy
04/06/2006CA2582225A1 Substituted dipiperdine ccr2 antagonists
04/05/2006EP1642895A2 Novel substituted naphthopyrans
04/05/2006EP1641802A2 Process for the preparation of furopyrroles
04/05/2006CN1756758A Novel cantharidimide and norcantharidimide derivant and its application in medicine
04/05/2006CN1754880A Process for preparing 2-iminopyrrolidine derivatives
04/05/2006CN1249227C 真菌细胞壁合成基因 Fungal cell wall synthesis genes
04/05/2006CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
04/05/2006CN1249063C Immunoregulatory compounds
04/05/2006CN1249057C Chromenylmethyl pyrimidinediamines as antibacterial agents
04/05/2006CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I
04/04/2006US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7
04/04/2006CA2262745C Highly lipophilic camptothecin derivatives
04/04/2006CA2043976C Substituted phthalides and heterocyclic phthalides
03/2006
03/30/2006WO2006034090A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
03/30/2006WO2006034015A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/30/2006WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
03/30/2006WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
03/30/2006WO2005102275A3 Galantamine salts, method of producing it and nasal composition thereof
03/30/2006WO2005097107A3 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
03/30/2006WO2005037825A3 Protein kinase inhibitors
03/30/2006US20060069251 Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof
03/30/2006US20060069116 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
03/30/2006US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood
03/30/2006US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/30/2006CA2581150A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors
03/30/2006CA2580777A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
03/29/2006EP1638978A2 7-substituted camptothecin and camptothecin analogs and methods for preparing same
03/29/2006EP1638977A1 Salinosporamides and methods for use thereof
03/29/2006EP1638976A1 Quinoline 3-amino chroman derivatives
03/29/2006EP1638957A1 N-heterocyclyl phenyl-substituted cyclic ketoenols
03/29/2006EP1638942A1 Cis-2,4,5-triaryl-imidazolines
03/29/2006EP1638568A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives
03/29/2006CN1753897A Fused bicyclic nitrogen-containing heterocycles
03/29/2006CN1753793A 成像系统 Imaging Systems
03/29/2006CN1753670A Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments
03/29/2006CN1247594C Bicyclic heteroaromatic compounds
03/29/2006CN1247591C Indole derivative and its medicine application
03/29/2006CN1247590C Process for synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f]quinoline
03/29/2006CN1247589C Tricyclic derivatives of indole with antiangiogenic activity
03/29/2006CN1247562C Method for production of spirocyclic tetronic acid derivatives
03/29/2006CN1247223C Method for preparing greater celandine extract with anticancer action
03/28/2006US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter)
03/28/2006US7019135 For therapy of viral infection
03/28/2006US7019003 Bactericides
03/28/2006US7019001 Substituted benzothiazole amide derivatives
03/28/2006US7018431 Useful as fluorescent labels of nucleosides, nucleotides, polynucleotides, and polypeptides.
03/28/2006US7018430 With novel pigment dyes based on naphthalimide; light-fast, thermostable, tinctorially strong colorations especially in the yellow color range; benzofuro(3,2-k)-7h-benzimidazo(2,1-a)benz(de)isoquinolin-7-one compounds
03/28/2006CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents
03/28/2006CA2253912C Taxane derivatives, the preparation thereof and formulations containing them
03/28/2006CA2147451C 3-indolylpiperidines
03/23/2006WO2006031770A1 Process for the scalable synthesis of 1, 3, 4, 9-tetrahydropyrano[3, 4-b]-indole derivatives
03/23/2006WO2006030124A1 Condensed pyrazole derivatives, preparation method thereof and therapeutic use of same
03/23/2006WO2006029799A1 Iodine-phenyl-substituted cyclic cetoenols
03/23/2006WO2006029532A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006WO2005000250A3 Imaging agents and methods of imaging alpha 7-nicotinic cholinergic receptor
03/23/2006US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
03/23/2006US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease
03/23/2006US20060063929 Process for preparing for imidazopyran derivatives
03/23/2006US20060063818 Hydantoin derivatives and deren verwendung als tace inhibitoren
03/23/2006US20060063815 Polymorphs of an epothilone analog
03/23/2006US20060063787 Condensed imidazole derivatives
03/23/2006US20060063761 Novel benzothiazole compounds and methods of use thereof
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006US20060063037 acts as a hole injection material, a hole transport material, a light emitting host, or a light emitting dopant in the organic light emitting device depending on the type of substituent
03/23/2006CA2580627A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006CA2580328A1 Iodine-phenyl-substituted cyclic ketoenols
03/23/2006CA2573508A1 Process for the scalable synthesis of 1, 3, 4, 9-tetrahydropyrano[3, 4-b]-indole derivatives
03/22/2006EP1636223A1 Benzothiazole derivatives as adenosine receptor ligands
03/22/2006EP1636218A1 Thiazolylpiperidine derivatives as mtp inhibitors
03/22/2006EP1636217A1 2-imidazo-benzothiazoles as adenosine receptor ligands
03/22/2006EP1636197A1 Novel 3-substituted-1,4-benzodiazepines
03/22/2006EP1497296B1 [1,4]DIAZOCINO[7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
03/22/2006EP1436296B1 Process for the direct preparation of pyrrolo[3,4-c]pyrroles
03/22/2006EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
03/22/2006EP1140924B1 Piperazine derivatives
03/22/2006CN1751048A Method for preparing polymorphism of irinotecan hydrochloride
03/22/2006CN1750825A Flavone acetic acid analogs and methods of use thereof
03/22/2006CN1749254A Double spiro material containing heteroaton and its synthetic method and use
03/22/2006CN1246323C Nitrogen-based camptothecin derivatives
03/22/2006CN1246322C Dehydrogenation 'nudike' alkali and preparation method as well as preparation method for synthesizing 'nudike' alkali
03/21/2006US7015334 Thermally stable booster explosive and process for manufacture
03/21/2006US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/21/2006US7015323 Resistant to metabolism having improved half-life and/or clearance properties compared to corresponding carbamate compounds; for example, N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; use to treat inflammatory diseases for example
03/21/2006US7015235 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/21/2006US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases
03/21/2006US7015218 Amide compounds and medicinal use thereof
03/21/2006US7015214 Such as 7-chloro-2-cyanoimino-5-(cyclopropylmethyloxy)-1,5-dihydro-5-trifluoromethyl-1,3-benzodiazepine
03/21/2006CA2315220C Integrin receptor antagonists
03/21/2006CA2270887C Methods and compositions for inhibition of angiogenesis
03/21/2006CA2134625C Substituted pyridylsalicylaldehyde or -salicylic acid derivatives, their preparation and their use as herbicides
03/16/2006WO2006029146A2 6H-[1]BENZOPYRANO[4,3-b]QUINOLINES AND THEIR USE AS ESTROGENIC AGENTS
03/16/2006WO2006028977A2 Chiral spiro compounds and their use in asymmetric catalytic reactions
03/16/2006WO2006028961A2 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
03/16/2006WO2006028525A2 [3.2.0] heterocyclic compounds and methods of using the same